Your browser doesn't support javascript.
loading
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Hugo, Willy; Zaretsky, Jesse M; Sun, Lu; Song, Chunying; Moreno, Blanca Homet; Hu-Lieskovan, Siwen; Berent-Maoz, Beata; Pang, Jia; Chmielowski, Bartosz; Cherry, Grace; Seja, Elizabeth; Lomeli, Shirley; Kong, Xiangju; Kelley, Mark C; Sosman, Jeffrey A; Johnson, Douglas B; Ribas, Antoni; Lo, Roger S.
Afiliação
  • Hugo W; Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Zaretsky JM; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Sun L; Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Song C; Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Moreno BH; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Hu-Lieskovan S; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Berent-Maoz B; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Pang J; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Chmielowski B; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Cherry G; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Seja E; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Lomeli S; Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Kong X; Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA.
  • Kelley MC; Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.
  • Sosman JA; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.
  • Johnson DB; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.
  • Ribas A; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of C
  • Lo RS; Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 9009
Cell ; 165(1): 35-44, 2016 Mar 24.
Article em En | MEDLINE | ID: mdl-26997480
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Melanoma / Anticorpos Monoclonais / Metástase Neoplásica / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Melanoma / Anticorpos Monoclonais / Metástase Neoplásica / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article